検索結果
2022
Ozawa, T. ,
Namkoong, H. ,
Takaya, R. ,
Takahashi, Y. ,
Fukunaga, K. ,
Enoki, Y. ,
Taguchi, K. ,
Kizu, J. ,
Matsumoto, K. &
Hasegawa, N. ,
2022 12月 ,
In: BMC infectious diseases. 22 ,
1 , 580.
研究成果: Article › 査読
Mycobacterium avium Complex
100%
Ethambutol
97%
Clarithromycin
77%
Drug-Related Side Effects and Adverse Reactions
70%
Rifampin
68%
Taguchi, K. ,
Hayashi, Y. ,
Ohuchi, M. ,
Yamada, H. ,
Yagishita, S. ,
Enoki, Y. ,
Matsumoto, K. &
Hamada, A. ,
2022 6月 1 ,
In: Drug metabolism and disposition: the biological fate of chemicals. 50 ,
6 ,
p. 822-826 5 p. 研究成果: Article › 査読
Nivolumab
100%
Clearance
79%
Chronic Renal Insufficiency
67%
Kidney
39%
Creatinine
14%
Watabe, Y. ,
Taguchi, K. ,
Sakai, H. ,
Enoki, Y. ,
Maruyama, T. ,
Otagiri, M. ,
Kohno, M. &
Matsumoto, K. ,
2022 1月 ,
In: European Journal of Pharmaceutics and Biopharmaceutics. 170 ,
p. 43-51 9 p. 研究成果: Article › 査読
Artificial Blood
100%
Blood Substitutes
89%
Bronchiolitis
78%
Macrophage Activation
72%
Interleukin-17
67%
Hanai, Y. ,
Takahashi, Y. ,
Niwa, T. ,
Mayumi, T. ,
Hamada, Y. ,
Kimura, T. ,
Matsumoto, K. ,
Fujii, S. &
Takesue, Y. ,
2022 4月 1 ,
In: Journal of Antimicrobial Chemotherapy. 77 ,
4 ,
p. 869-879 11 p. 研究成果: Article › 査読
Teicoplanin
100%
Drug Monitoring
84%
Practice Guidelines
68%
Methicillin-Resistant Staphylococcus aureus
56%
Drug Therapy
43%
Iketani, O. ,
Komeya, A. ,
Enoki, Y. ,
Taguchi, K. ,
Uno, S. ,
Uwamino, Y. ,
Matsumoto, K. ,
Kizu, J. &
Hasegawa, N. ,
2022 1月 ,
In: Journal of Infection and Chemotherapy. 28 ,
1 ,
p. 61-66 6 p. 研究成果: Article › 査読
Mycobacterium avium Complex
100%
Clarithromycin
90%
Rifampin
80%
Pharmacokinetics
57%
14-hydroxyclarithromycin
54%
Ichinose, N. ,
Yoshikawa, G. ,
Fukao, E. ,
Takahata, T. ,
Ichisawa, M. ,
Enoki, Y. ,
Taguchi, K. ,
Oda, T. ,
Tsutsumi, K. &
Matsumoto, K. ,
2022 8月 ,
In: Journal of Infection and Chemotherapy. 28 ,
8 ,
p. 1216-1219 4 p. 研究成果: Article › 査読
Ceftazidime
100%
Ceftriaxone
97%
Meningitis
83%
Cerebrospinal Fluid
72%
Proteins
30%
Kunishima, H. ,
Ohge, H. ,
Suzuki, H. ,
Nakamura, A. ,
Matsumoto, K. ,
Mikamo, H. ,
Mori, N. ,
Morinaga, Y. ,
Yanagihara, K. ,
Yamagishi, Y. &
Yoshizawa, S. ,
2022 8月 ,
In: Journal of Infection and Chemotherapy. 28 ,
8 ,
p. 1045-1083 39 p. 研究成果: Article › 査読
Taguchi, K. ,
Suzuki, Y. ,
Tsutsuura, M. ,
Hiraoka, K. ,
Watabe, Y. ,
Enoki, Y. ,
Otagiri, M. ,
Sakai, H. &
Matsumoto, K. ,
2022 1月 ,
In: Pharmaceutics. 14 ,
1 , 57.
研究成果: Article › 査読
Blood Substitutes
100%
Carbon Monoxide
71%
Acute Kidney Injury
66%
Cisplatin
63%
Erythrocytes
55%
Suzuki, Y. ,
Taguchi, K. ,
Kure, T. ,
Enoki, Y. ,
Otagiri, M. ,
Sakai, H. &
Matsumoto, K. ,
2022 9月 1 ,
In: Toxicology and Applied Pharmacology. 450 , 116159.
研究成果: Article › 査読
Antidote
100%
Methemoglobin
96%
Hydrogen Sulfide
90%
Antidotes
88%
Poisoning
70%
Suzuki, Y. ,
Taguchi, K. ,
Okamoto, W. ,
Enoki, Y. ,
Komatsu, T. &
Matsumoto, K. ,
2022 9月 ,
In: Journal of Controlled Release. 349 ,
p. 304-314 11 p. 研究成果: Article › 査読
Methemoglobin
100%
Hydrogen Sulfide
93%
Albumins
61%
Molecular Cluster
46%
Lethal
28%
Gotoda, M. ,
Enoki, Y. ,
Shishido, S. ,
Taguchi, K. &
Matsumoto, K. ,
2022 1月 ,
In: Toxicology Reports. 9 ,
p. 1255-1260 6 p. 研究成果: Article › 査読
Colistin
100%
Sevoflurane
99%
methanesulfonic acid
97%
Methanesulfonate
83%
Neurotoxicity
76%
Suzuki, Y. ,
Taguchi, K. ,
Hanyu, S. ,
Kure, T. ,
Enoki, Y. ,
Otagiri, M. ,
Sakai, H. &
Matsumoto, K. ,
2022 5月 ,
In: Journal of Drug Delivery Science and Technology. 71 , 103282.
研究成果: Article › 査読
Blood Substitutes
100%
Azides
99%
Methemoglobin
97%
Lethal
84%
Electron Transport Complex IV
82%
Hanaya, K. ,
Yamoto, K. ,
Taguchi, K. ,
Matsumoto, K. ,
Higashibayashi, S. &
Sugai, T. ,
2022 , (Accepted/In press)
In: Chemistry - A European Journal. 研究成果: Article › 査読
Aldol Reaction
100%
Proteins
80%
Copper
71%
Amino acids
52%
Modification
49%
Ito, C. ,
Taguchi, K. ,
Moroi, Y. ,
Enoki, Y. ,
Tokuda, R. ,
Yamasaki, K. ,
Imoto, S. &
Matsumoto, K. ,
2022 8月 ,
In: Journal of Pharmaceutical Sciences. 111 ,
8 ,
p. 2201-2209 9 p. 研究成果: Article › 査読
Tritylation
100%
Trityl Group
95%
Cytidine
84%
gemcitabine
67%
Prodrugs
67%
Ueda, T. ,
Takesue, Y. ,
Nakajima, K. ,
Ichiki, K. ,
Ishikawa, K. ,
Yamada, K. ,
Tsuchida, T. ,
Otani, N. ,
Takahashi, Y. ,
Ishihara, M. ,
Takubo, S. ,
Ikeuchi, H. ,
Uchino, M. ,
Kimura, T. ,
Matsumoto, K. ,
Oda, K. &
Kimura, T. ,
2022 1月 ,
In: Antibiotics. 11 ,
1 , 96.
研究成果: Article › 査読
Cmin
100%
Vancomycin
94%
Bayes Theorem
90%
Staphylococcal Infections
84%
Methicillin-Resistant Staphylococcus aureus
75%
2021
Uchida, H. ,
Sakaguchi, T. ,
Hongo, I. ,
Shinoda, K. ,
Tashiro, S. ,
Matsumoto, K. ,
Samura, M. ,
Kato, T. ,
Sekiguchi, M. ,
Nakajima, M. ,
Mitsuda, M. &
Kawai, Y. ,
2021 11月 ,
In: Japanese Journal of Chemotherapy. 69 ,
6 ,
p. 433-439 7 p. 研究成果: Article › 査読
Ceftriaxone
100%
Brain Diseases
81%
Renal Dialysis
74%
Body Weight
61%
Anti-Bacterial Agents
56%
Moriyama, M. ,
Liu, X. ,
Enoki, Y. ,
Matsumoto, K. &
Tanabe, Y. ,
2021 9月 ,
In: Pharmaceuticals. 14 ,
9 , 938.
研究成果: Article › 査読
naphthol BINOL
100%
titanium isopropoxide
93%
Methicillin-Resistant Staphylococcus aureus
43%
Product R
41%
3-hydroxybutanal
39%
Hashimoto, N. ,
Kimura, T. ,
Hamada, Y. ,
Niwa, T. ,
Hanai, Y. ,
Chuma, M. ,
Fujii, S. ,
Matsumoto, K. ,
Shigemi, A. ,
Kawamura, H. ,
Takahashi, Y. &
Takesue, Y. ,
2021 12月 ,
In: Journal of Global Antimicrobial Resistance. 27 ,
p. 12-19 8 p. 研究成果: Article › 査読
Vancomycin
100%
Risk Reduction Behavior
96%
Acute Kidney Injury
89%
Area Under Curve
76%
Tazobactam Drug Combination Piperacillin
7%
Takemura, W. ,
Tashiro, S. ,
Hayashi, M. ,
Igarashi, Y. ,
Liu, X. ,
Mizukami, Y. ,
Kojima, N. ,
Morita, T. ,
Enoki, Y. ,
Taguchi, K. ,
Yokoyama, Y. ,
Nakamura, T. &
Matsumoto, K. ,
2021 11月 ,
In: Pharmaceutical research. 38 ,
11 ,
p. 1839-1846 8 p. 研究成果: Article › 査読
Cefmetazole
100%
Carbapenems
81%
Escherichia coli Infections
69%
beta-Lactamases
57%
Microbial Sensitivity Tests
40%
Ichinose, N. ,
Yoshikawa, G. ,
Fukao, E. ,
Ichisawa, M. ,
Takahata, T. ,
Enoki, Y. ,
Taguchi, K. ,
Oda, T. ,
Tsutsumi, K. &
Matsumoto, K. ,
2021 9月 ,
In: International Journal of Infectious Diseases. 110 ,
p. 382-384 3 p. 研究成果: Article › 査読
Linezolid
100%
Meningitis
78%
Cerebrospinal Fluid
42%
Drainage
33%
Spinal Puncture
23%
Matsubara, K. ,
Matsumoto, K. ,
Yokoyama, Y. ,
Watanabe, E. ,
Enoki, Y. ,
Shigemi, A. ,
Ikawa, K. ,
Terazono, H. ,
Morikawa, N. ,
Ohshige, T. &
Takeda, Y. ,
2021 5月 ,
In: Biological and Pharmaceutical Bulletin. 44 ,
5 ,
p. 732-736 5 p. 研究成果: Article › 査読
sultamicillin
100%
Cystatin C
88%
Ampicillin
88%
Pneumonia
56%
Time Schedule of Dosing
55%
Hanai, Y. ,
Hamada, Y. ,
Kimura, T. ,
Matsumoto, K. ,
Takahashi, Y. ,
Fujii, S. ,
Nishizawa, K. ,
Miyazaki, Y. &
Takesue, Y. ,
2021 4月 ,
In: Journal of Fungi. 7 ,
4 , 306.
研究成果: Article › 査読
systematic review
100%
Voriconazole
97%
odds ratio
95%
meta-analysis
87%
confidence interval
82%
Samura, M. ,
Hirose, N. ,
Kurata, T. ,
Takada, K. ,
Nagumo, F. ,
Koshioka, S. ,
Ishii, J. ,
Uchida, M. ,
Inoue, J. ,
Enoki, Y. ,
Taguchi, K. ,
Higashita, R. ,
Kunika, N. ,
Tanikawa, K. &
Matsumoto, K. ,
2021 12月 1 ,
In: Open Forum Infectious Diseases. 8 ,
12 , ofab568.
研究成果: Article › 査読
Daptomycin
100%
Creatine Kinase
75%
Incidence
34%
Confidence Intervals
19%
Odds Ratio
16%
Suzuki, Y. ,
Taguchi, K. ,
Kure, T. ,
Sakai, H. ,
Enoki, Y. ,
Otagiri, M. &
Matsumoto, K. ,
2021 9月 10 ,
In: Journal of Controlled Release. 337 ,
p. 59-70 12 p. 研究成果: Article › 査読
Antidote
100%
Methemoglobin
96%
Cyanides
90%
Antidotes
88%
Poisoning
70%
Suzuki, Y. ,
Taguchi, K. ,
Kure, T. ,
Enoki, Y. ,
Otagiri, M. ,
Sakai, H. &
Matsumoto, K. ,
2021 12月 15 ,
In: International Journal of Pharmaceutics. 610 , 121260.
研究成果: Article › 査読
Antidote
100%
Methemoglobin
96%
Cyanides
90%
Antidotes
88%
Poisoning
70%
Enoki, Y. ,
Kishi, N. ,
Sakamoto, K. ,
Uchiyama, E. ,
Hayashi, Y. ,
Suzuki, N. ,
Ito, M. ,
Taguchi, K. ,
Yokoyama, Y. ,
Kizu, J. &
Matsumoto, K. ,
2021 4月 ,
In: Drug Metabolism And Pharmacokinetics. 37 , 100371.
研究成果: Article › 査読
Dolutegravir
100%
dolutegravir
84%
polycations
77%
Polycationic Polymer
61%
Cations
53%
Hanai, Y. ,
Takahashi, Y. ,
Niwa, T. ,
Mayumi, T. ,
Hamada, Y. ,
Kimura, T. ,
Matsumoto, K. ,
Fujii, S. &
Takesue, Y. ,
2021 6月 ,
In: Journal of Clinical Pharmacy and Therapeutics. 46 ,
3 ,
p. 622-632 11 p. 研究成果: Article › 査読
Teicoplanin
100%
Staphylococcal Infections
84%
Methicillin-Resistant Staphylococcus aureus
75%
Meta-Analysis
54%
Systematic Reviews
54%
Oda, K. ,
Hashiguchi, Y. ,
Kimura, T. ,
Tsuji, Y. ,
Shoji, K. ,
Takahashi, Y. ,
Matsumoto, K. ,
Kawamura, H. ,
Saito, H. &
Takesue, Y. ,
2021 4月 ,
In: Pharmaceutical research. 38 ,
4 ,
p. 637-646 10 p. 研究成果: Article › 査読
Vancomycin
100%
Sampling
64%
Area Under Curve
63%
Application
24%
Drug
20%
Watanabe, E. ,
Matsumoto, K. ,
Ikawa, K. ,
Yokoyama, Y. ,
Shigemi, A. ,
Enoki, Y. ,
Umezaki, Y. ,
Nakamura, K. ,
Ueno, K. ,
Terazono, H. ,
Morikawa, N. &
Takeda, Y. ,
2021 3月 ,
In: Journal of Global Antimicrobial Resistance. 24 ,
p. 83-87 5 p. 研究成果: Article › 査読
Teicoplanin
100%
Staphylococcus aureus
63%
Thigh
59%
Pharmacokinetics
55%
Methicillin-Resistant Staphylococcus aureus
50%
Tashiro, S. ,
Hayashi, M. ,
Takemura, W. ,
Igarashi, Y. ,
Liu, X. ,
Mizukami, Y. ,
Kojima, N. ,
Enoki, Y. ,
Taguchi, K. ,
Yokoyama, Y. ,
Nakamura, T. &
Matsumoto, K. ,
2021 1月 ,
In: Pharmaceutical research. 38 ,
1 ,
p. 27-35 9 p. 研究成果: Article › 査読
Flomoxef
100%
flomoxef
80%
beta-Lactamases
51%
Microbial Sensitivity Tests
51%
Thigh
39%
Samura, M. ,
Takada, K. ,
Yamamoto, R. ,
Ito, H. ,
Nagumo, F. ,
Uchida, M. ,
Kurata, T. ,
Koshioka, S. ,
Enoki, Y. ,
Taguchi, K. ,
Higashita, R. ,
Kunika, N. ,
Tanikawa, K. &
Matsumoto, K. ,
2021 , (Accepted/In press)
In: Pharmaceutical research. 研究成果: Article › 査読
Daptomycin
100%
Cystatin C
76%
Hypoalbuminemia
75%
Chronic Renal Insufficiency
55%
Dose
46%
Sakamoto, Y. ,
Isono, H. ,
Enoki, Y. ,
Taguchi, K. ,
Miyazaki, T. ,
Kunimoto, H. ,
Koike, H. ,
Hagihara, M. ,
Matsumoto, K. ,
Nakajima, H. ,
Sahashi, Y. &
Matsumoto, K. ,
2021 11月 ,
In: Journal of Fungi. 7 ,
11 , 975.
研究成果: Article › 査読
fluconazole
100%
Fluconazole
84%
pharmacokinetics
83%
Hematologic Neoplasms
74%
Pharmacokinetics
55%
Kuroda, T. ,
Minamijima, Y. ,
Niwa, H. ,
Tamura, N. ,
Mita, H. ,
Fukuda, K. ,
Kaimachi, M. ,
Suzuki, Y. ,
Enoki, Y. ,
Taguchi, K. ,
Matsumoto, K. ,
Toutain, P. L. ,
Bousquet-Melou, A. &
Kasashima, Y. ,
2021 11月 ,
In: Equine Veterinary Journal. 53 ,
6 ,
p. 1239-1249 11 p. 研究成果: Article › 査読
cefazolin
100%
Cephalothin
96%
cephalothin
92%
Cefazolin
89%
pharmacodynamics
89%
Enoki, Y. ,
Igarashi, Y. ,
Watabe, Y. ,
Honma, K. ,
Suzuki, Y. ,
Hayashi, Y. ,
Hiraoka, K. ,
Taguchi, K. &
Matsumoto, K. ,
2021 3月 ,
In: Journal of Global Antimicrobial Resistance. 24 ,
p. 81-82 2 p. 研究成果: Article › 査読
Misawa, K. ,
Iketani, O. ,
Enoki, Y. ,
Taguchi, K. ,
Uno, S. ,
Uwamino, Y. ,
Hasegawa, N. &
Matsumoto, K. ,
2021 10月 ,
In: Journal of Infection and Chemotherapy. 27 ,
10 ,
p. 1407-1412 6 p. 研究成果: Article › 査読
Metronidazole
100%
Vancomycin
93%
Retrospective Studies
59%
Safety
51%
Infections
42%
Sakamoto, Y. ,
Kawabe, K. ,
Suzuki, T. ,
Sano, K. ,
Ide, K. ,
Nishigaki, T. ,
Enoki, Y. ,
Taguchi, K. ,
Koike, H. ,
Kato, H. ,
Sahashi, Y. &
Matsumoto, K. ,
2021 8月 ,
In: Journal of Fungi. 7 ,
8 , 596.
研究成果: Article › 査読
micafungin
100%
Micafungin
87%
Candida parapsilosis
82%
Candidemia
81%
Candida
64%
Akahane, M. ,
Enoki, Y. ,
Saiki, R. ,
Hayashi, Y. ,
Hiraoka, K. ,
Honma, K. ,
Itagaki, M. ,
Gotoda, M. ,
Shinoda, K. ,
Hanyu, S. ,
Hamamura, Y. ,
Miyajima, T. ,
Ito, C. ,
Taguchi, K. ,
Uno, S. ,
Uwamino, Y. ,
Iketani, O. ,
Hasegawa, N. &
Matsumoto, K. ,
2021 2月 ,
In: International Journal of Infectious Diseases. 103 ,
p. 464-468 5 p. 研究成果: Article › 査読
Infusion Pumps
100%
Anti-Infective Agents
77%
Outpatients
57%
Cefmetazole
33%
Tazobactam Drug Combination Piperacillin
28%
Tsutsuura, M. ,
Moriyama, H. ,
Kojima, N. ,
Mizukami, Y. ,
Tashiro, S. ,
Osa, S. ,
Enoki, Y. ,
Taguchi, K. ,
Oda, K. ,
Fujii, S. ,
Takahashi, Y. ,
Hamada, Y. ,
Kimura, T. ,
Takesue, Y. &
Matsumoto, K. ,
2021 12月 ,
In: BMC infectious diseases. 21 ,
1 , 153.
研究成果: Article › 査読
Vancomycin
100%
Area Under Curve
76%
Meta-Analysis
70%
Systematic Reviews
69%
Odds Ratio
60%
Moriyama, H. ,
Tsutsuura, M. ,
Kojima, N. ,
Mizukami, Y. ,
Tashiro, S. ,
Osa, S. ,
Enoki, Y. ,
Taguchi, K. ,
Oda, K. ,
Fujii, S. ,
Takahashi, Y. ,
Hamada, Y. ,
Kimura, T. ,
Takesue, Y. &
Matsumoto, K. ,
2021 5月 ,
In: Journal of Infection and Chemotherapy. 27 ,
5 ,
p. 781-785 5 p. 研究成果: Article › 査読
Vancomycin
100%
Meta-Analysis
70%
Systematic Reviews
69%
Pediatrics
60%
Methicillin-Resistant Staphylococcus aureus
48%
Ohuchi, M. ,
Yagishita, S. ,
Taguchi, K. ,
Goto, Y. ,
Fukahori, M. ,
Enoki, Y. ,
Shimada, T. ,
Yamaguchi, M. ,
Matsumoto, K. &
Hamada, A. ,
2021 1月 1 ,
In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 1162 , 122489.
研究成果: Article › 査読
Nivolumab
100%
Peptides
46%
Plasma
45%
Antibodies
15%
Pharmacokinetics
13%
2020
Osa, S. ,
Tashiro, S. ,
Igarashi, Y. ,
Watabe, Y. ,
Liu, X. ,
Enoki, Y. ,
Taguchi, K. ,
Mayumi, T. ,
Miyazaki, Y. ,
Takesue, Y. &
Matsumoto, K. ,
2020 11月 ,
In: Journal of Infection and Chemotherapy. 26 ,
11 ,
p. 1232-1236 5 p. 研究成果: Article › 査読
Candidemia
100%
Azoles
92%
Amphotericin B
80%
Meta-Analysis
54%
Polyenes
53%
Taguchi, K. ,
Ogaki, S. ,
Nagasaki, T. ,
Yanagisawa, H. ,
Nishida, K. ,
Maeda, H. ,
Enoki, Y. ,
Matsumoto, K. ,
Sekijima, H. ,
Ooi, K. ,
Ishima, Y. ,
Watanabe, H. ,
Fukagawa, M. ,
Otagiri, M. &
Maruyama, T. ,
2020 3月 ,
In: Journal of Pharmacology and Experimental Therapeutics. 372 ,
3 ,
p. 355-365 11 p. 研究成果: Article › 査読
Rhabdomyolysis
100%
Carbon Monoxide
81%
Acute Kidney Injury
76%
Crush Syndrome
74%
Theoretical Models
65%
Taguchi, K. ,
Chuang, V. T. G. ,
Hashimoto, M. ,
Nakayama, M. ,
Sakuragi, M. ,
Enoki, Y. ,
Nishi, K. ,
Matsumoto, K. ,
Seo, H. ,
Otagiri, M. &
Yamasaki, K. ,
2020 ,
In: Chemical and Pharmaceutical Bulletin. 68 ,
8 ,
p. 766-772 7 p. 研究成果: Article › 査読
Lactoferrin
100%
Desolvation
95%
Nanoparticles
70%
Cattle
64%
Glutaral
39%
Enoki, Y. ,
Suzuki, N. ,
Ito, M. ,
Uchiyama, E. ,
Kishi, N. ,
Ito, C. ,
Kitahiro, Y. ,
Sakamoto, K. ,
Taguchi, K. ,
Yokoyama, Y. ,
Kizu, J. &
Matsumoto, K. ,
2020 10月 1 ,
In: Journal of Pharmacy and Pharmacology. 72 ,
10 ,
p. 1361-1369 9 p. 研究成果: Article › 査読
Raltegravir
100%
Raltegravir Potassium
85%
Polycationic Polymer
67%
Cations
58%
bixalomer
56%
Yamashita, C. ,
Takesue, Y. ,
Matsumoto, K. ,
Ikegame, K. ,
Enoki, Y. ,
Uchino, M. ,
Miyazaki, T. ,
Izumikawa, K. ,
Takada, T. ,
Okinaka, K. ,
Ueda, T. ,
Miyazaki, Y. &
Mayumi, T. ,
2020 6月 ,
In: Journal of Infection and Chemotherapy. 26 ,
6 ,
p. 596-603 8 p. 研究成果: Article › 査読
Echinocandins
100%
Febrile Neutropenia
88%
Hematologic Diseases
82%
Meta-Analysis
53%
Systematic Reviews
52%
Tashiro, S. ,
Osa, S. ,
Igarashi, Y. ,
Watabe, Y. ,
Liu, X. ,
Enoki, Y. ,
Taguchi, K. ,
Mayumi, T. ,
Miyazaki, Y. ,
Takesue, Y. &
Matsumoto, K. ,
2020 11月 ,
In: Journal of Infection and Chemotherapy. 26 ,
11 ,
p. 1164-1176 13 p. 研究成果: Article › 査読
Invasive Candidiasis
100%
Echinocandins
97%
Meta-Analysis
51%
Randomized Controlled Trials
46%
Odds Ratio
29%
Samura, M. ,
Hirose, N. ,
Kurata, T. ,
Ishii, J. ,
Nagumo, F. ,
Takada, K. ,
Koshioka, S. ,
Uchida, M. ,
Yamamoto, S. ,
Inoue, J. ,
Enoki, Y. ,
Taguchi, K. ,
Ishida, A. ,
Sekine, H. ,
Kunika, N. ,
Kunishima, H. &
Matsumoto, K. ,
2020 3月 ,
In: Journal of Infection and Chemotherapy. 26 ,
3 ,
p. 272-279 8 p. 研究成果: Article › 査読
Antimicrobial Stewardship
100%
Mycoses
76%
Pharmacists
74%
Candidemia
52%
Health Expenditures
38%
2019
Kuroda, Y. ,
Taguchi, K. ,
Enoki, Y. ,
Matsumoto, K. ,
Hori, S. &
Kizu, J. ,
2019 ,
In: Biological and Pharmaceutical Bulletin. 42 ,
8 ,
p. 1423-1427 5 p. 研究成果: Article › 査読
1,3-dimethyluric acid
100%
1,3-dimethyluric Acid
98%
Theophylline
63%
Metabolic
43%
Acids
18%
Hashimoto, M. ,
Iketani, O. ,
Ichinose, N. ,
Enoki, Y. ,
Taguchi, K. ,
Uno, S. ,
Uwamino, Y. ,
Hasegawa, N. &
Matsumoto, K. ,
2019 9月 ,
In: Journal of Infection and Chemotherapy. 25 ,
9 ,
p. 735-737 3 p. 研究成果: Article › 査読
Vancomycin
100%
Body Mass Index
48%
Obesity
18%
Body Weight
9%
Ando, G. ,
Taguchi, K. ,
Enoki, Y. ,
Yokoyama, Y. ,
Kizu, J. &
Matsumoto, K. ,
2019 ,
In: Biological and Pharmaceutical Bulletin. 42 ,
11 ,
p. 1799-1804 6 p. 研究成果: Article › 査読
Ganciclovir
100%
Drug-Related Side Effects and Adverse Reactions
74%
Databases
48%
Drug
42%
Time
28%